Demant A/S

Copenhagen Stock Exchange DEMANT.CO

Demant A/S Capital Expenditure for the year ending December 31, 2023: USD -125.22 M

Demant A/S Capital Expenditure is USD -125.22 M for the year ending December 31, 2023, a 5.56% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Demant A/S Capital Expenditure for the year ending December 31, 2022 was USD -132.59 M, a -20.16% change year over year.
  • Demant A/S Capital Expenditure for the year ending December 31, 2021 was USD -110.35 M, a 1.07% change year over year.
  • Demant A/S Capital Expenditure for the year ending December 31, 2020 was USD -111.55 M, a 2.72% change year over year.
  • Demant A/S Capital Expenditure for the year ending December 31, 2019 was USD -114.67 M, a -20.80% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
Copenhagen Stock Exchange: DEMANT.CO

Demant A/S

Description

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Similar companies

ROCK-B.CO

Rockwool A/S

USD 337.75

-4.88%

ISS.CO

ISS A/S

USD 18.85

-0.12%

AMBU-B.CO

Ambu A/S

USD 18.27

-2.30%

GN.CO

GN Store Nord A/S

USD 19.40

-5.69%

COLO-B.CO

Coloplast A/S

USD 111.76

-2.99%

StockViz Staff

February 5, 2025

Any question? Send us an email